Survival of Patients with Acute Coronary Syndrome and Hematologic Malignancies-A Real-World Analysis.

ABSTRACT:

Background

The impact of the encounter between coronary heart disease (CHD) and cancer, and in particular hematologic malignancies (HM), remains poorly understood.

Objective

The aim of this analysis was to clarify how HM affects the prognosis of acute coronary syndrome (ACS). We analyzed German health insurance data from 11 regional Ortskrankenkassen (AOK) of patients hospitalized for ACS between January 2010 and December 2018, matched by age, sex and all comorbidities for short- and long-term survival and major adverse cardiac events (MACE).

Results

Of 439,716 patients with ACS, 2104 (0.5%) also had an HM. Myelodysplastic/myeloproliferative disorders (27.7%), lymphocytic leukemias (24.8%), and multiple myeloma (22.4%) predominated. These patients were about 6 years o

SUBMITTER: Lange SA 

PROVIDER: S-EPMC10605274 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature